Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature

Pancreatic adenocarcinoma carries a devastating prognosis. For locally advanced and metastatic disease, several chemotherapeutic regimens are currently being used. Over the past years, novel approaches have included targeting EGFR, NTRK, PARP, K-Ras as well as stroma and fibrosis, leading to approva...

Descripción completa

Detalles Bibliográficos
Autores principales: Schlick, Konstantin, Kiem, Dominik, Greil, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533343/
https://www.ncbi.nlm.nih.gov/pubmed/34680101
http://dx.doi.org/10.3390/biom11101469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533343/
https://www.ncbi.nlm.nih.gov/pubmed/34680101
http://dx.doi.org/10.3390/biom11101469

Ejemplares similares